Alnylam Pharmaceuticals
ALNY
#578
Rank
NZ$61.09 B
Marketcap
$472.03
Share price
-0.94%
Change (1 day)
83.70%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

Alnylam Pharmaceuticals (ALNY) - Net assets

Net assets on the balance sheet as of December 2024 : NZ$0.11 Billion

According to Alnylam Pharmaceuticals 's latest financial reports the company has NZ$0.11 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Alnylam Pharmaceuticals - Net assets on balance sheet (from 2003 to 2024)

Net assets by year

Year Net assets Change
2024-12-31$NZ$0.11 B-134.09%
2023-12-31$-NZ$0.35 Billion40%
2022-12-31$-NZ$0.25 Billion-128.94%
2021-12-31$NZ$0.86 B-38.86%
2020-12-31$NZ$1.40 B-34.07%
2019-12-31$NZ$2.13 B10.06%
2018-12-31$NZ$1.94 B-21.96%
2017-12-31$NZ$2.48 B87.22%
2016-12-31$NZ$1.32 B-28.11%
2015-12-31$NZ$1.84 B54.64%
2014-12-31$NZ$1.19 B263.23%
2013-12-31$NZ$0.32 B101.89%
2012-12-31$NZ$0.16 B7.78%
2011-12-31$NZ$0.15 B-26.29%
2010-12-31$NZ$0.20 B-16.29%
2009-12-31$NZ$0.24 B-29.65%
2008-12-31$NZ$0.34 B33.96%
2007-12-31$NZ$0.26 B-8.94%
2006-12-31$NZ$0.28 B215.93%
2005-12-31$NZ$90.38 M39.78%
2004-12-31$NZ$64.66 M-257.4%
2003-12-31$-NZ$41.09 Million362.8%
2002-12-31$-NZ$8.88 Million

Net assets for similar companies or competitors

Company Net assets differencediff. Country
NZ$98.59 M-16.42%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$51.61 B 43,653.88%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$2.68 B 2,177.22%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$2.40 B 1,935.31%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$0.13 B 13.89%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$77.58 B 65,673.31%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
NZ$142.45 B 120,665.56%๐Ÿ‡ซ๐Ÿ‡ท France
NZ$10.05 B 8,426.11%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel